Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-29 @ 4:38 AM
Study NCT ID:
NCT02963766
Status:
COMPLETED
Last Update Posted:
2022-07-01
First Post:
2016-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-12
Completion Date Type:
ACTUAL
First Submit Date:
2016-11-10
First Submit QC Date:
None
Study First Post Date:
2016-11-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-06-07
Results First Submit QC Date:
None
Results First Post Date:
2022-07-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-07
Last Update Post Date:
2022-07-01
Last Update Post Date Type:
ACTUAL